Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma

NCT07274397 is registered in ClinicalTrials.gov with Beta Emitting Accurate Monitored Systems as lead sponsor.

NCT NCT07274397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma
Lead sponsor
Beta Emitting Accurate Monitored Systems
Phase
Not applicable
Overall status
Recruiting
Start date
April 17, 2026
Completion date
April 17, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain imaging, brain tumors, glioblastoma